Myriad takes genetic tests to UK, Ireland and Canada
This article was originally published in Clinica
Myriad Genetics has formed two agreements for its molecular diagnostic cancer tests - in the UK/Ireland and in Canada. Myriad says the two deals are part of its strategy to expand its molecular diagnostics business into "multiple foreign markets during 2000". Last month it signed an exclusive licensing agreement with Japanese company Falco biosystems.